LAURUSLABS

Laurus Labs Share PriceLaurus Labs

₹297.05
7.3 (2.52%)
As on 30 March, 2023 | 14:27 BSE: 540222 NSE: LAURUSLABS

Laurus Labs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Laurus Labs

Start SIP

Laurus Labs Share Price

  • Over 1 Month -5.5%
  • Over 3 Month -20.32%
  • Over 6 Month -41.69%
  • Over 1 Year -50%

Laurus Labs Key Statistics

P/E Ratio 17.4
PEG Ratio 6.5
Market Cap Cr 16,001
Price to Book Ratio 4.8
EPS 13.9
Dividend 0.7
Relative Strength Index 35.2
Money Flow Index 34.85
MACD Signal -8.39
Average True Range 7.82

Laurus Labs Investment Rating

  • Master Rating:
  • Laurus Labs has an operating revenue of Rs. 6,084.48 Cr. on a trailing 12-month basis. An annual revenue growth of 2% is not great, Pre-tax margin of 22% is great, ROE of 24% is exceptional. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 94 which is a GREAT score indicating consistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Laurus Labs Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1,5011,4981,4951,378
Operating Expenses Qtr Cr 1,1161,0721,0771,005
Operating Profit Qtr Cr 385426418373
Depreciation Qtr Cr 78766661
Interest Qtr Cr 39382829
Tax Qtr Cr 71899664
Net Profit Qtr Cr 199227232221

Laurus Labs Technicals

EMA & SMA

Current Price
₹297.05
7.3 (2.52%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 306.15
  • 50 Day
  • 326.85
  • 100 Day
  • 364.74
  • 200 Day
  • 416.73
  • 20 Day
  • 305.86
  • 50 Day
  • 323.24
  • 100 Day
  • 366.36
  • 200 Day
  • 440.92

Laurus Labs Resistance and Support

PIVOT
₹292.45
Resistance
First Resistance 296.11
Second Resistance 302.45
Third Resistance 306.11
RSI 35.21
MFI 34.85
MACD Single Line -8.39
MACD -8.32
Support
First Resistance 286.11
Second Resistance 282.45
Third Resistance 276.11

Laurus Labs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,129,262 108,251,680 50.84
Week 1,201,886 60,070,262 49.98
1 Month 1,176,992 53,058,784 45.08
6 Month 1,713,805 72,254,003 42.16

Laurus Labs Result Highlights

Laurus Labs Synopsis

NSE-Medical-Diversified

Laurus Labs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 4707.04 Cr. and Equity Capital is Rs. 107.47 Cr. for the Year ended 31/03/2022. Laurus Labs Ltd. is a Public Limited Listed company incorporated on 19/09/2005 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24239AP2005PLC047518 and registration number is 047518.
Market Cap 16,001
Sales 5,872
Shares in Float 39.32
No of funds 221
Yield 0.67
Book Value 4.71
U/D Vol ratio 0.5
LTDebt / Equity 16
Alpha -0.24
Beta 0.78

Laurus Labs

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 27.2%27.27%27.27%
Mutual Funds 5.41%5.5%4.77%
Insurance Companies 3.92%3.48%
Foreign Portfolio Investors 21.9%22.67%21.96%
Financial Institutions/ Banks
Individual Investors 28.95%27.96%28.42%
Others 12.62%13.12%17.58%

Laurus Labs Management

Name Designation
Dr. M Venu Gopala Rao Non Exe.Chairman&Ind.Director
Dr. C V Lakshmana Rao Executive Director
Dr. Satyanarayana Chava Executive Director & CEO
Mr. V V Ravi Kumar Executive Director & CFO
Mr. Chandrakanth Chereddi Non Executive Director
Dr. Ravindranath Kancherla Independent Director
Mrs. Aruna Rajendra Bhinge Independent Director
Dr. Rajesh Koshy Chandy Independent Director

Laurus Labs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Laurus Labs MF Shareholding

Name Amount(cr)
HDFC Balanced Advantage Fund Growth 51042
Kotak Emerging Equity Scheme Growth 23963
Kotak Equity Arbitrage Fund Growth 21918
ICICI Prudential Equity Arbitrage Fund Regular Growth 11273
Nippon India Arbitrage Fund Growth 9234

Laurus Labs FAQs

What is Share Price of Laurus Labs ?

Laurus Labs share price is ₹297 As on 30 March, 2023 | 14:13

What is the Market Cap of Laurus Labs ?

The Market Cap of Laurus Labs is ₹16000.6 Cr As on 30 March, 2023 | 14:13

What is the P/E ratio of Laurus Labs ?

The P/E ratio of Laurus Labs is 17.4 As on 30 March, 2023 | 14:13

What is the PB ratio of Laurus Labs ?

The PB ratio of Laurus Labs is 4.8 As on 30 March, 2023 | 14:13

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number